TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8112284

Group type: EXPERIMENTAL
Intervention: Flunitrazepam 2 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Triazolam 0.25 mg
Number of subjects: 15
Study: 3073803

Group type: EXPERIMENTAL
Intervention: Terbutaline SR 7.5 mg b.i.d.
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Terbutaline SR 7.5 mg in the morning and 15 mg in the evening
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo b.i.d.
Number of subjects: 9
Study: 29189347

Group type: EXPERIMENTAL
Intervention: Exenatide (17.4 μg infusion for 6 hours and 15 minutes)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study: 26690312

Group type: EXPERIMENTAL
Intervention: Latest generation drug-eluting stent (SYNERGY™ II; Boston Scientific)
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Bare metal stent (Rebel™; Boston Scientific)
Number of subjects: 1200
Study: 26348175

Group type: EXPERIMENTAL
Intervention: Collaborative midwifery and laborist model
Number of subjects: 4884
Study: 23032073

Group type: EXPERIMENTAL
Intervention: ABT-894 (4 mg BID)
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Atomoxetine (40 mg BID)
Number of subjects: 243

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 243
Study: 20606094

Group type: EXPERIMENTAL
Intervention: Gemcitabine plus cetuximab
Number of subjects: 720

Group type: COMPARATOR
Intervention: Gemcitabine
Number of subjects: 720
Study: 18714250

Group type: EXPERIMENTAL
Intervention: Open skill warm-up (15 minutes)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Closed skill warm-up (15 minutes)
Number of subjects: 14
Study: 16152838

Group type: EXPERIMENTAL
Intervention: Vertebral manipulation (VM) therapy
Number of subjects: 150

Group type: COMPARATOR
Intervention: Acupuncture therapy
Number of subjects: 150
Study: 12940469

Group type: EXPERIMENTAL
Intervention: Familias Unidas intervention
Number of subjects: 167

Group type: COMPARATOR
Intervention: No-intervention control
Number of subjects: 167
Study: 10488597

Group type: EXPERIMENTAL
Intervention: Glutamine (0.3 g/kg enterally for 5 days)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Casein (0.3 g/kg enterally for 5 days)
Number of subjects: 9
Study: 8561067

Group type: EXPERIMENTAL
Intervention: 100 g butter
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 50 g butter
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 40 g olive oil
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 80 g olive oil
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fat content of meals (various fats)
Number of subjects: 12
Study: 1877740

Group type: EXPERIMENTAL
Intervention: Disulfiram (DS) implant (10 x 100 mg DS tablets)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo (9 x 100 mg calcium phosphate tablets + 1 mg DS tablet)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Disulfiram (DS) implant
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Both groups (DS and PL)
Number of subjects: 76
Study: 7015215

Group type: EXPERIMENTAL
Intervention: Oxatomide (30 mg b.i.d. for 4 weeks)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Oxatomide
Number of subjects: 35
Study: 31142546

Group type: EXPERIMENTAL
Intervention: Cell phone counseling intervention
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Medication Possession Ratio (MPR) >90%
Number of subjects: 404
Study: 28476263

Group type: EXPERIMENTAL
Intervention: 5-session family-based integrated substance use and HIV/STI prevention intervention
Number of subjects: 47

Group type: COMPARATOR
Intervention: Adolescent-only psychoeducation condition
Number of subjects: 47
Study: 25251443

Group type: EXPERIMENTAL
Intervention: Paraneoplastic Ma antigen-like 1 positive expression
Number of subjects: 50

Group type: COMPARATOR
Intervention: Negative expression of Paraneoplastic Ma antigen-like 1
Number of subjects: 50
Study: 23353608

Group type: EXPERIMENTAL
Intervention: Gilthead sea bream fillets fed with 100% fishmeal (FM)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Gilthead sea bream fillets fed with partial replacement with plant proteins (PP)
Number of subjects: 20
Study: 21670471

Group type: EXPERIMENTAL
Intervention: Thalidomide plus melphalan and prednisone (MPT)
Number of subjects: 1685
Study: 19191134

Group type: EXPERIMENTAL
Intervention: Telephone intervention with asthma-specific questionnaire
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group with general health questionnaire
Number of subjects: 52
Study: 18193693

Group type: EXPERIMENTAL
Intervention: Comfrey extract
Number of subjects: 164

Group type: COMPARATOR
Intervention: Diclofenac gel
Number of subjects: 164
Study: 15017112

Group type: EXPERIMENTAL
Intervention: Tc‐99m‐HIgG
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: In‐111‐HIgG
Number of subjects: 55

Group type: COMPARATOR
Intervention: T‐B transport in BCRL (involved hand)
Number of subjects: 55

Group type: COMPARATOR
Intervention: T‐B transport in BCRL (spared hand)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Minimum time to arrival of radioprotein in blood
Number of subjects: 55
Study: 11822849

Group type: EXPERIMENTAL
Intervention: Bug busting (combing with special combs and hair conditioner)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Phenothrin lotion
Number of subjects: 30
Study: 9726802

Group type: EXPERIMENTAL
Intervention: ACE inhibitors (captopril 25 to 50 mg daily or enalapril 10 to 40 mg daily)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 11
Study: 8277547

Group type: EXPERIMENTAL
Intervention: Educational pamphlet on the durable power of attorney for health care and a durable power of attorney for health care form mailed to patients
Number of subjects: 1101

Group type: COMPARATOR
Intervention: Conventional care only (Control)
Number of subjects: 1101
Study: 2568072

Group type: EXPERIMENTAL
Intervention: Active TENS
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo TENS
Number of subjects: 30

Group type: COMPARATOR
Intervention: No TENS
Number of subjects: 30
Study: 785297

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 31702622

Group type: EXPERIMENTAL
Intervention: Training intervention for healthcare workers
Number of subjects: 1113

Group type: COMPARATOR
Intervention: Financial subsidy for pregnant women
Number of subjects: 1113
Study: 28592581

Group type: EXPERIMENTAL
Intervention: Discontinuation of antibiotic therapy
Number of subjects: 240

Group type: COMPARATOR
Intervention: Usual strategy of continuing antibiotic treatment
Number of subjects: 240
Study: 26088151

Group type: EXPERIMENTAL
Intervention: Chronic Respiratory Disease Questionnaire (CRDQ)
Number of subjects: 85
Study: 23757295

Group type: EXPERIMENTAL
Intervention: Patterned Sensory Enhancement (PSE) music combined with exercise
Number of subjects: 36

Group type: COMPARATOR
Intervention: No-music group
Number of subjects: 36
Study: 21607703

Group type: EXPERIMENTAL
Intervention: Calcium fructoborate supplementation for 15 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 19759043

Group type: EXPERIMENTAL
Intervention: Once-daily dosing (ODD) of gentamicin
Number of subjects: 400

Group type: COMPARATOR
Intervention: Multiple daily dosing (MDD) of gentamicin
Number of subjects: 400
Study: 17726314

Group type: EXPERIMENTAL
Intervention: Moderate beer consumption (330 ml for women and 660 ml for men) for 30 days
Number of subjects: 57
Study: 16335304

Group type: EXPERIMENTAL
Intervention: Immunomodulatory cytokines
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cytokines with antimicrobial agents
Number of subjects: 0
Study: 11723892

Group type: COMPARATOR
Intervention: Total Parenteral Nutrition (TPN)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Early Enteral Nutrition (EEN)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Early Enteral Immunonutrition (EEIN)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: EEN and EEIN
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: EEN
Number of subjects: 171
Study: 9501404

Group type: EXPERIMENTAL
Intervention: IVIG infusion rate of 0.08 ml/kg/min
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: IVIG infusion rate of 0.06 ml/kg/min
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: IVIG infusion rate of 0.04 ml/kg/min
Number of subjects: 42
Study: 7995386

Group type: COMPARATOR
Intervention: 0.1 mg ANP inhalation
Number of subjects: 11

Group type: COMPARATOR
Intervention: 1 mg ANP inhalation
Number of subjects: 11

Group type: COMPARATOR
Intervention: 5 mg ANP inhalation
Number of subjects: 11

Group type: COMPARATOR
Intervention: Nebulized salbutamol (control)
Number of subjects: 11
Study: 2457768

Group type: EXPERIMENTAL
Intervention: Captopril 1 mg
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Captopril 5 mg
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Captopril 25 mg
Number of subjects: 5

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 5
Study: 30952135

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 222

Group type: COMPARATOR
Intervention: Nonoperative treatment
Number of subjects: 222
Study: 28198785

Group type: EXPERIMENTAL
Intervention: Ocriplasmin
Number of subjects: 62

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 62
Study: 27068497

Group type: EXPERIMENTAL
Intervention: S-1 (tegafur, gimeracil, and oteracil potassium) concurrent with 3D-conformal radiotherapy (60Gy)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Gemcitabine concurrent with 3D-conformal radiotherapy (control group)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: S-1 (tegafur, gimeracil, and oteracil potassium)
Number of subjects: 106
Study: 25445313

Group type: EXPERIMENTAL
Intervention: Continuous PDS suture reinforced with GORE BIO‐A Tissue Reinforcement prosthesis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Continuous PDS suture only
Number of subjects: 0
Study: 21748252

Group type: EXPERIMENTAL
Intervention: ABT-089 40 mg QD
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: ABT-089 40 mg BID
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: ABT-089 (all doses)
Number of subjects: 221

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 221
Study: 18828797

Group type: EXPERIMENTAL
Intervention: Naltrexone with Medical Management (MM) without Combined Behavioral Intervention (CBI)
Number of subjects: 618

Group type: COMPARATOR
Intervention: Placebo with Medical Management (MM) without Combined Behavioral Intervention (CBI)
Number of subjects: 618

Group type: EXPERIMENTAL
Intervention: Combined Behavioral Intervention (CBI)
Number of subjects: 618
Study: 17880017

Group type: EXPERIMENTAL
Intervention: HPC5 group (5/mm3)
Number of subjects: 45

Group type: COMPARATOR
Intervention: HPC50 group (50/mm3)
Number of subjects: 45
Study: 16098001

Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg b.d. (RCM group)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Omeprazole 20 mg b.d. (OCM group)
Number of subjects: 150
Study: 12182969

Group type: EXPERIMENTAL
Intervention: Pilocarpine (5-mg tablets) three times daily for 1 month after treatment
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo three times daily for 1 month after treatment
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Pilocarpine
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study: 9794348

Group type: EXPERIMENTAL
Intervention: Direct PTCA in AMI
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (elective PTCA)
Number of subjects: 20
Study: 7662753

Group type: EXPERIMENTAL
Intervention: Computer-based biofeedback system 1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Computer-based biofeedback system 2
Number of subjects: 0
Study: 2675768

Group type: EXPERIMENTAL
Intervention: Preoperative irradiation
Number of subjects: 166

Group type: COMPARATOR
Intervention: No preoperative irradiation (Control)
Number of subjects: 166
Study: 16319303

Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 31124947

Group type: EXPERIMENTAL
Intervention: Mibyeongbogam (MBBG) mobile application for 12 weeks
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 150
Study: 28367916

Group type: EXPERIMENTAL
Intervention: Dulaglutide 0.75 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Liraglutide 0.9 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dulaglutide
Number of subjects: 0
Study: 25430415

Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg/day
Number of subjects: 22
Study: 23336124

Group type: EXPERIMENTAL
Intervention: Mirror therapy (MT), 30 minutes a day, five days a week for three weeks, plus half an hour conventional rehabilitation after each MT session
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group observed the affected hand instead of using mirror therapy, same treatment programme as intervention group
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Mirror therapy (MT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group observed the affected hand instead of using mirror therapy
Number of subjects: 30
Study: 21463037

Group type: EXPERIMENTAL
Intervention: Applied Tension (AT) technique
Number of subjects: 737

Group type: COMPARATOR
Intervention: Control group (no AT)
Number of subjects: 737
Study: 18291345

Group type: EXPERIMENTAL
Intervention: Tecnis Z9001 IOL with modified anterior surface
Number of subjects: 25

Group type: COMPARATOR
Intervention: ClariFlex IOL
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Tecnis Z9001 IOL
Number of subjects: 25
Study: 16526896

Group type: EXPERIMENTAL
Intervention: Conjunctival reflectance spectra with PLS analysis
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Conjunctival reflectance spectra with discrete spectral region model
Number of subjects: 30

Group type: COMPARATOR
Intervention: In vitro measurement of hemoglobin
Number of subjects: 30
Study: 14594652

Group type: EXPERIMENTAL
Intervention: Controlled heading for 55 minutes
Number of subjects: 61

Group type: COMPARATOR
Intervention: Normal exercise for 61 minutes
Number of subjects: 61

Group type: COMPARATOR
Intervention: CCT+ group (patients after TBI)
Number of subjects: 61
Study: 10630380

Group type: EXPERIMENTAL
Intervention: GLP-1 (0.4 pmol/min/kg body weight)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: GLP-1 (1.2 pmol/min/kg body weight)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 10
Study: 9360208

Group type: EXPERIMENTAL
Intervention: Ultrafiltrated whey formula
Number of subjects: 0

Group type: COMPARATOR
Intervention: Electrodialyzed whey formula
Number of subjects: 0
Study: 1548648

Group type: EXPERIMENTAL
Intervention: Controlled-release ketoprofen
Number of subjects: 50

Group type: COMPARATOR
Intervention: Diclofenac
Number of subjects: 50
Study: 2582017

Group type: EXPERIMENTAL
Intervention: Encainide (50 mg three times a day)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Disopyramide (200 mg three times a day)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Encainide
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Disopyramide
Number of subjects: 10
Study: 31688331

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.5 μg/kg)
Number of subjects: 223

Group type: COMPARATOR
Intervention: 0.9% sodium chloride (saline)
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 223
Study: 29882261

Group type: EXPERIMENTAL
Intervention: Short-term ureter catheter for 6 hours
Number of subjects: 141

Group type: COMPARATOR
Intervention: Double-J stent insertion for 5 days
Number of subjects: 141
Study: 27411591

Group type: EXPERIMENTAL
Intervention: Dabigatran
Number of subjects: 5107

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 5107
Study: 25057102

Group type: EXPERIMENTAL
Intervention: Therapeutic lumbar punctures (LPs)
Number of subjects: 248

Group type: COMPARATOR
Intervention: No therapeutic lumbar punctures
Number of subjects: 248
Study: 22661448

Group type: EXPERIMENTAL
Intervention: Neurally adjusted ventilatory assist (NAVA)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Pressure support ventilation (PSV)
Number of subjects: 13
Study: 20692140

Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol 320/9 microg
Number of subjects: 111

Group type: COMPARATOR
Intervention: Formoterol 9 microg
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study: 18797738

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (monthly medical visits and education)
Number of subjects: 50
Study: 15699225

Group type: EXPERIMENTAL
Intervention: Statin diet (20 mg lovastatin)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Portfolio diet (high in plant sterols, soy-protein foods, almonds, viscous fibers)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control diet (very-low-saturated-fat diet)
Number of subjects: 34
Study: 12971709

Group type: EXPERIMENTAL
Intervention: General programme of psychomotor therapy
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Personalized psychomotor fitness programme
Number of subjects: 199
Study: 10897124

Group type: EXPERIMENTAL
Intervention: MOPPEBVCAD
Number of subjects: 67

Group type: COMPARATOR
Intervention: MOPPEBVCyED
Number of subjects: 67
Study: 8622245

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 902

Group type: EXPERIMENTAL
Intervention: Beta-blocker (acebutolol)
Number of subjects: 902

Group type: EXPERIMENTAL
Intervention: Calcium antagonist (amlodipine)
Number of subjects: 902

Group type: EXPERIMENTAL
Intervention: Diuretic (chlorthalidone)
Number of subjects: 902

Group type: EXPERIMENTAL
Intervention: Alpha1-antagonist (doxazosin)
Number of subjects: 902

Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme inhibitor (enalapril)
Number of subjects: 902

Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 902

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 902
Study: 1383173

Group type: EXPERIMENTAL
Intervention: Ultrafast computed tomography (UFCT) videotape
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Cardiac dissection
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Cardiac dissection and UFCT videotape
Number of subjects: 180

Group type: COMPARATOR
Intervention: No instruction (control group)
Number of subjects: 180
Study: 6319147

Group type: EXPERIMENTAL
Intervention: Combination chemotherapy
Number of subjects: 21
Study: 31655509

Group type: EXPERIMENTAL
Intervention: pSS group
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study: 30466402

Group type: EXPERIMENTAL
Intervention: Oxytocin (8.3 μg or 5 U)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 27301730

Group type: EXPERIMENTAL
Intervention: Modified chevron osteotomy
Number of subjects: 84

Group type: COMPARATOR
Intervention: Scarf osteotomy
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 84
Study: 25082573

Group type: EXPERIMENTAL
Intervention: PCI
Number of subjects: 0

Group type: COMPARATOR
Intervention: CABG
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: sSS-based SS II
Number of subjects: 0
Study: 22759406

Group type: EXPERIMENTAL
Intervention: Back‐Shu and Front‐Mu acupoints of Large Intestine meridians (Shu‐Mu points group)
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: He‐Sea and Lower He‐Sea acupoints of Large Intestine meridians (He points group)
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: Combining used Back‐Shu, Front‐Mu, He‐Sea, and Lower He‐Sea acupoints of Large Intestine meridians (Shu‐Mu‐He points group)
Number of subjects: 700

Group type: COMPARATOR
Intervention: Mosapride Citrate (control group)
Number of subjects: 700
Study: 20472091

Group type: EXPERIMENTAL
Intervention: Lactic acid bacteria (LN strains)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study: 18076268

Group type: EXPERIMENTAL
Intervention: Including the contribution of body mass in force output (IBM)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Including the contribution of the mass of body less the mass of the shanks and feet in force output (IBMS)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Excluding the contribution of body mass in force output (EBM)
Number of subjects: 12
Study: 15871654

Group type: EXPERIMENTAL
Intervention: Evidence-based medicine (EBM) methods applied to drug utilization patterns
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: General medical research
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: General medical care
Number of subjects: 0
Study: 12196660

Group type: EXPERIMENTAL
Intervention: 10 g Semmes‐Weinstein monofilament (touch/pressure sensation)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neurothesiometer (vibration perception threshold)
Number of subjects: 0
Study: 11083193

Group type: EXPERIMENTAL
Intervention: Intravenous nicorandil (4 mg in 5 minutes at admission, followed by 6 mg/hr over 24 hours)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Intravenous nicorandil
Number of subjects: 62
Study: 9437273

Group type: EXPERIMENTAL
Intervention: Paracetamol-dextropropoxyphene
Number of subjects: 2231

Group type: COMPARATOR
Intervention: Paracetamol
Number of subjects: 2231
Study: 8123120

Group type: EXPERIMENTAL
Intervention: Chloroquine 300 mg weekly and proguanil 100 mg daily
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Chloroquine 300 mg weekly and proguanil 200 mg daily
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Proguanil 200 mg daily
Number of subjects: 58
Study: 3021499

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium 4 mg q.i.d.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium 2 mg q.i.d.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29406429

Group type: EXPERIMENTAL
Intervention: B‐TasP adherence and sexual health intervention
Number of subjects: 500

Group type: COMPARATOR
Intervention: General health control intervention
Number of subjects: 500
Study: 27084751

Group type: EXPERIMENTAL
Intervention: MyPregn@ncy (Personal Health Record)
Number of subjects: 4500

Group type: COMPARATOR
Intervention: Control group (standard maternity care without PHR)
Number of subjects: 4500